Trial intelligence / Profile preview

GLP-1 for Glycemic Control in Critically Ill Surgical Patients

NCT00798590Phase 2Terminated

Sponsor
Johns Hopkins University
Start
Dec 2008
Primary completion
Jun 2010
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of Glucagon-like peptide 1 in hyperglycemia, sponsored by Johns Hopkins University. Started Dec 2008; status: terminated.

02

Drugs

Glucagon-like peptide 1
03

Conditions

hyperglycemia

Beyond the preview

Go deeper on NCT00798590.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00798590.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call